Alpha Teknova (TKNO) Work In Process (2020 - 2026)

Alpha Teknova (TKNO) reported Work In Process of $206000.0 for Q1 2026, up 390.48% year-over-year from $42000.0 in Q1 2025, and up 103.96% quarter-over-quarter from $101000.0 in Q4 2025.

Alpha Teknova (TKNO) Work In Process (2020 - 2026) Analysis & Trends

Alpha Teknova (TKNO) has 7 years of Work In Process data on file, last reported at $206000.0 in Q1 2026.

  • Work In Process for Q1 2026 came in at $206000.0, up 390.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $206000.0 (up 390.48% YoY), and the FY2025 annual result was $101000.0, up 320.83% from the prior year.
  • Work In Process rose to $206000.0 in Q1 2026 per TKNO's latest filing, from $101000.0 in the prior quarter.
  • Over five years, Work In Process peaked at $276000.0 in Q1 2024 and troughed at $24000.0 in Q4 2024.
  • A 5-year average of $123000.0 and a median of $112000.0 in 2025 frame the typical range for Work In Process.
  • The sharpest annual moves came in 2025 and 2026: Work In Process slumped 84.78% in 2025, then soared 390.48% in 2026.
  • A 5-year view of Work In Process shows it stood at $186000.0 in 2022, then sank by 74.73% to $47000.0 in 2023, then slumped by 48.94% to $24000.0 in 2024, then surged by 320.83% to $101000.0 in 2025, then surged by 103.96% to $206000.0 in 2026.
  • Business Quant data shows TKNO's Work In Process at $206000.0 in Q1 2026, $101000.0 in Q4 2025, and $112000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Alpha Teknova 249.27 Mn 231.49 Mn 3.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 206,000.00
Dec 31, 2025 101,000.00
Sep 30, 2025 112,000.00
Jun 30, 2025 87,000.00
Mar 31, 2025 42,000.00
Dec 31, 2024 24,000.00
Sep 30, 2024 134,000.00
Jun 30, 2024 140,000.00
Mar 31, 2024 276,000.00
Dec 31, 2023 47,000.00
Sep 30, 2023 58,000.00
Jun 30, 2023 108,000.00
Mar 31, 2023 155,000.00
Dec 31, 2022 186,000.00
Sep 30, 2022 138,000.00
Jun 30, 2022 109,000.00
Mar 31, 2022 168,000.00
Dec 31, 2021 105,000.00
Sep 30, 2021 88,000.00
Jun 30, 2021 79,000.00